Erlotinib Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Erlotinib Side Effects
Did You Have Erlotinib Side Effect? |
Erlotinib Side Effects Poll Results |
|
Vote Below:
|
|
Erlotinib Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Erlotinib:
What is Your Question? Ask Community:
Daily Health Videos
Erlotinib Side Effects reported on Patientsville.com
None reported at this time.Erlotinib Side Effects reported to FDA
Showing 1-50 of 1515 Next >
Erlotinib Side Effects Report #5203379-6Physician from BELGIUM reported Erlotinib side effect on Dec 21, 2006. Male patient, 61 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ascites infection, candidiasis, computerised tomogram abnormal, escherichia infection, gastrointestinal perforation, iatrogenic injury, sepsis
, staphylococcal infection . Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, OMIC, LACTULOSE, TRAZOLAN, TRADONAL, VOLTAREN, ZANTAC, LAXOBERON. Patient died on 11/10/2006.
Erlotinib Side Effects Report #5203381-4
Erlotinib side effect was reported by a Physician from HONG KONG on Dec 22, 2006. Female patient was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: escherichia urinary tract infection, lung neoplasm malignant, rash
, urinary tract infection enterococcal. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient died on 12/27/2005.Erlotinib Side Effects Report #5203396-6
Physician from PERU reported Erlotinib side effect on Dec 21, 2006. Male patient, 74 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, haemoglobin decreased, hypovolaemic shock, malabsorption, no therapeutic response. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized and became disabled. Patient died.
Erlotinib Side Effects Report #5203400-5
Erlotinib side effect was reported by a Health Professional from CANADA on Dec 20, 2006. Female patient, 50 years of age, was diagnosed with colorectal cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, intestinal obstruction, rash , small intestinal obstruction. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CAPECITABINE, LOPERAMIDE, MAGNESIUM HYDROXIDE, COLACE, POTASSIUM CHLORIDE, METHYLPHENIDATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5215813-6
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 12, 2007. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, candidiasis, dysphagia, haemoglobin decreased, hiccups, mucosal inflammation, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5216877-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 04, 2007. Male patient, 47 years of age, weighting 196.2 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac arrest
, hypotension, myocardial infarction, pericardial effusion, pleural effusion. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TARGRETIN, METHADONE, ATIVAN, MORPHINE, PREDNISONE, DUONEB, NITROGLYCERIN, ALBUTEROL SULPHATE. Patient died.Erlotinib Side Effects Report #5216889-2
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 02, 2007. Female patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, gastrointestinal perforation, haemorrhage, inappropriate antidiuretic hormone secretion, iron deficiency anaemia. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, REGLAN, PROCRIT. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5216929-0
Erlotinib side effect was reported by a Physician from SWITZERLAND on Nov 17, 2006. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, gastrointestinal haemorrhage, gastrointestinal inflammation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5216966-6
Health Professional from GREECE reported Erlotinib side effect on Jan 02, 2007. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: respiratory tract haemorrhage, thrombocytopenia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with IRBESARTAN, SALOSPIR, ISOSORBIDE MONONITRATE, LABETALOL. Patient was hospitalized. Patient died on 11/12/2006.
Erlotinib Side Effects Report #5217471-3
Erlotinib side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 03, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax, pulmonary cavitation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5217473-7
Physician from DENMARK reported Erlotinib side effect on Jan 03, 2007. Female patient, 46 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, oesophagobronchial fistula. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LYRICA, PRIMPERAN, LACTULOSE, ACTILAX, PREDNISOLONE, LORAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5222610-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 09, 2007. Male patient, 62 years of age, weighting 93.92 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: oesophagitis. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5222614-1
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 08, 2007. Male patient, 56 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspiration, blood chloride increased, blood pressure decreased, blood sodium increased, carbon dioxide decreased, coagulopathy, confusional state, gastrointestinal haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, DILAUDID, OXYCONTIN, VICODIN, MAGNESIUM CHLORIDE, PHENERGAN, MARINOL, TUSSINEX. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5223021-8
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 09, 2007. Male patient, 51 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, pancreatic carcinoma metastatic. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with GEMCITABINE, NOVOMIX, CIPROFLOXACIN, CITODON, MORPHINE SULPHATE, EBASTINE, CAPECITABINE. Patient died on 12/24/2006.
Erlotinib Side Effects Report #5223022-X
Physician from FRANCE reported Erlotinib side effect on Jan 08, 2007. Female patient, 56 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with PAROXETINE, NOCTAMIDE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5224125-6
Erlotinib side effect was reported by a Health Professional from NETHERLANDS on Jan 10, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anal fistula, malignant neoplasm progression, myocardial infarction, myocardial ischaemia, pancreatic carcinoma metastatic, sepsis
. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5224126-8
Physician from DENMARK reported Erlotinib side effect on Jan 12, 2007. Male patient, 54 years of age, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abnormal faeces, decubitus ulcer, gastric haemorrhage, haemorrhagic disorder, hepatic failure, ill-defined disorder, laboratory test abnormal, malignant neoplasm progression, metastases to liver. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, ATENOLOL, DURAGESIC, PINEX, AMLODIPINE, CITALOPRAM HYDROBROMIDE, PANTOPRAZOLE, PREDNISOLONE. Patient was hospitalized. Patient died on 10/06/2006.
Erlotinib Side Effects Report #5224439-X
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 12, 2007. Male patient, 88 years of age, was diagnosed with prostate cancer
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatine increased, blood glucose increased, cardiac failure congestive, haemoglobin decreased, lung infiltration, nausea , pleural effusion, pulmonary oedema. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with SYNTHROID, HUMULIN, FUROSEMIDE, COREG, LISINOPRIL, FERROUS SULPHATE, LEUPROLIDE ACETATE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5224445-5
Physician from UNITED STATES reported Erlotinib side effect on Jan 12, 2007. Male patient, 52 years of age, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, pain
. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5224657-0
Erlotinib side effect was reported by a Physician from DENMARK on Jan 10, 2007. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: confusional state, memory impairment, metastases to central nervous system. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, EMPERAL, PAMOL, OXAZEPAM, MAGNESIUM HYDROXIDE, MORPHINE, POTASSIUM CHLORIDE, ZOPICLONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5229275-6
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 27, 2007. Male patient, 65 years of age, weighting 197.5 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: interstitial lung disease, lymphadenopathy, pneumonia
, pulmonary oedema, respiratory failure. Erlotinib dosage: 150 MG, QD. During the same period patient was treated with AVASTIN, OXYGEN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5230793-5
Erlotinib side effect was reported by a Physician from PHILIPPINES on Jan 19, 2007. Female patient, 45 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: unknown. During the same period patient was treated with GEMCITABINE, CARBOPLATIN, OXYCODONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5230795-9
Physician from TAIWAN, PROVINCE OF CHINA reported Erlotinib side effect on Jan 26, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, diabetes mellitus inadequate control, disease progression, necrosis, pleural effusion, pneumonia
, pneumothorax, subcutaneous emphysema, tuberculosis . Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5230797-2
Erlotinib side effect was reported by a Physician from GERMANY on Jan 19, 2007. Male patient, 65 years of age, was diagnosed with bronchial carcinoma, lung neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, pleural effusion. Erlotinib dosage: unknown. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5230798-4
Physician from UNITED KINGDOM reported Erlotinib side effect on Jan 17, 2007. Male patient, 59 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: depressed mood, fatigue, left ventricular failure, pleural effusion, vomiting. Erlotinib dosage: 100 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMEPRAZOLE, LOPERAMIDE, METOCLOPRAMIDE, FUROSEMIDE, SPIRONOLACTONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5230805-9
Erlotinib side effect was reported by a Physician from FRANCE on Jan 29, 2007. Female patient, 48 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bone swelling. Erlotinib dosage: unknown. During the same period patient was treated with ERYTHROMYCIN. Patient recovered.
Erlotinib Side Effects Report #5231284-8
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 19, 2007. Male patient, 64 years of age, weighting 162.0 lb, was diagnosed with colon cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, nausea
. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TOPOTECAN, PHENERGAN, PERCOCET, PAXIL, ARANESP. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5232502-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 06, 2007. Female patient, weighting 119.0 lb, was diagnosed with lung cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, disease progression, metastases to bone. Erlotinib dosage: 150 MG DAILY ORAL. During the same period patient was treated with BEVACIZUMAB. Patient died on 02/04/2007.
Erlotinib Side Effects Report #5234262-8
Physician from UNITED STATES reported Erlotinib side effect on Jan 22, 2007. Female patient, 70 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: vision blurred, visual disturbance, visual field defect. Erlotinib dosage: 150 MG (Q3W), ORAL. During the same period patient was treated with PEMETREXED, PROTONIX, FOSAMAX, SYNTHROID, DARVOCET, VITAMIN, PROCRIT. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5235109-6
Erlotinib side effect was reported by a Physician from AUSTRIA on Jan 22, 2007. Female patient, 66 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: ileus. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with PACLITAXEL, CARBOPLATIN. Patient recovered.
Erlotinib Side Effects Report #5235111-4
Physician from POLAND reported Erlotinib side effect on Jan 23, 2007. Male patient, 74 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, diarrhoea, fatigue. Erlotinib dosage: unknown. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5235112-6
Erlotinib side effect was reported by a Physician from FRANCE on Jan 22, 2007. Male patient, 80 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, glossitis. Erlotinib dosage: unknown. During the same period patient was treated with DILTIAZEM, DAFALGAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5236719-2
Physician from GERMANY reported Erlotinib side effect on Jan 24, 2007. Male patient, 51 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: duodenal ulcer haemorrhage, duodenal ulcer perforation, multi-organ failure, respiratory failure. Erlotinib dosage: 150 MG (QD); ORAL. Patient died.
Erlotinib Side Effects Report #5237023-9
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, haemoptysis, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea
, performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, KLEXANE, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5237874-0
Physician from UNITED STATES reported Erlotinib side effect on Jan 24, 2007. Male patient, 62 years of age, weighting 93.92 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: infection
, mucosal inflammation, oesophageal stenosis, radiation injury, rash pustular, weight decreased. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5237875-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 25, 2007. Female patient, 51 years of age, weighting 215.0 lb, was diagnosed with breast cancer metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal distension, ascites, asthenia, gastrointestinal disorder, metastases to liver. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5242857-0
Physician from UNITED STATES reported Erlotinib side effect on Jan 29, 2007. Male patient, 76 years of age, weighting 178.6 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: small intestinal obstruction. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, TOPROL, LIPITOR, NIASPAN, NITROSTAT, ASPIRIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5242980-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 30, 2007. Female patient, 38 years of age, was diagnosed with neoplasm malignant, cervix carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hypokalaemia, hypomagnesaemia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with CETUXIMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5243099-5
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 29, 2007. Female patient, 60 years of age, weighting 94.14 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cachexia, chronic obstructive pulmonary disease. Erlotinib dosage: 150 MG QD, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5243422-1
Erlotinib side effect was reported by a Physician from SPAIN on Jan 29, 2007. Female patient, 44 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral artery embolism. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient died.
Erlotinib Side Effects Report #5243442-7
Physician from GERMANY reported Erlotinib side effect on Jan 30, 2007. Female patient, 75 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: erythema multiforme. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ALLOPURINOL, OXYBUTYNIN CHLORIDE, ASPIRIN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5243827-9
Erlotinib side effect was reported by a Physician from GERMANY on Jan 31, 2007. Male patient, 68 years of age, was diagnosed with pancreatic carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, inflammation, leukocytosis. Erlotinib dosage: 100 MG (QD); ORAL. During the same period patient was treated with GEMCITABINE. Patient died.
Erlotinib Side Effects Report #5243831-0
Health Professional from SWEDEN reported Erlotinib side effect on Feb 05, 2007. Male patient, 51 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardiac arrest
, disease progression. Erlotinib dosage: 100 MG (QD); ORAL. During the same period patient was treated with GEMCITABINE, NOVOMIX, CIPROFLOXACIN, CITODON, MORPHINE SULPHATE, CAPECITABINE, OXALIPLATIN. Patient died on 12/24/2006.Erlotinib Side Effects Report #5243835-8
Erlotinib side effect was reported by a Physician from DENMARK on Jan 31, 2007. Female patient, 46 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, erosive oesophagitis, malignant neoplasm progression, metastases to lung, oesophageal cancer metastatic, oesophagobronchial fistula. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with BEVACIZUMAB, LYRICA, PRIMPERAN, LACTULOSE, ACTILAX, PREDNISOLONE, LORAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5244800-7
Physician from SWITZERLAND reported Erlotinib side effect on Feb 02, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: hemiparesis, malignant neoplasm progression, syncope. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, ASPIRIN, FRAGMIN. Patient was hospitalized. Patient died on 12/30/2006.
Erlotinib Side Effects Report #5245531-X
Erlotinib side effect was reported by a Consumer or non-health professional from NETHERLANDS on Feb 01, 2007. Male patient, 57 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anal abscess, anal fistula, malignant neoplasm progression, myocardial infarction, myocardial ischaemia, pancreatic carcinoma, sepsis
. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5245532-1
Physician from TAIWAN, PROVINCE OF CHINA reported Erlotinib side effect on Feb 02, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, disease progression, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5245676-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 01, 2007. Male patient, 62 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood calcium increased. Erlotinib dosage: 50 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CETUXIMAB. Patient died on 01/10/2007.
Erlotinib Side Effects Report #5245856-8
Health Professional from UNITED STATES reported Erlotinib side effect on Jan 31, 2007. Male patient, 52 years of age, weighting 220.0 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, pain
, white blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, ALBUTEROL, CELEXA, SEROQUEL, PEPCID. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5248071-7
Erlotinib side effect was reported by a Physician from BELGIUM on Feb 05, 2007. Female patient, 59 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.
Showing 1-50 of 1515 Next >
Advise and Guidance
Nausea and Dealing with drug side effects - part 1
Pain and Energy medicine: an overview
Pain and Helpful treatments keep people with arthritis moving
Pain and Joint replacement: an inside look
Pain and Manipulative and body-based practices: an overview
Pain and Menopause: medicines to help you
Pain and Mind-body medicine: an overview
Pain and Rheumatoid arthritis and complementary and alternative medicine
Pain and Spinal manipulation for low-back pain
Pain and Symptoms of serious health conditions
Pain and What makes your head hurt?
Pain and What is chronic fatigue syndrome (cfs)?
Pain and What is a sexually transmitted disease (std)?